| Vol. 9.06 – 16 February, 2021 |
| |
|
|
| Researchers leveraged single-cell RNA sequencing to chart the gene expression and clonal landscape of tumor-infiltrating T cells across 31 patients with isocitrate dehydrogenase (IDH) wild-type glioblastoma and IDH mutant glioma. [Cell] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists conducted a first-in-human, Phase I clinical trial of T cells engineered with a T cell receptor targeting HPV-16 E7 for the treatment of metastatic human papilloma virus-associated epithelial cancers. [Nature Medicine] |
|
|
|
| The authors discovered that brain tumor cells had a particularly high demand for oxygen, which affected γδ T cell-mediated antitumor immune responses but not those of conventional T cells. [Nature Immunology] |
|
|
|
| Investigators provide a comprehensive roadmap of human B cell maturation with single-cell transcriptomics matched with bulk and single-cell antibody repertoires to define gene expression, antibody repertoires, and clonal sharing of B cell states at single-cell resolution. [Science Immunology] |
|
|
|
| Immunocompetent mouse models and in vitro co-culture assays demonstrated that EPIC1 induced tumor immune evasion and resistance to immunotherapy by suppressing tumor cell antigen presentation. [Science Advances] |
|
|
|
| Scientists showed that CD4+ T cells from patients with rheumatoid arthritis and psoriatic arthritis had increased expression of the pore-forming calcium channel component ORAI3. [Nature Communications] |
|
|
|
| Using fate-mapping mice, researchers reported that prostaglandin I2 signaling prevented Treg reprogramming toward a pathogenic phenotype. [Journal of Clinical Investigation] |
|
|
|
| Using single-cell RNA-seq, cell mass spectrometry, flow cytometry, and functional analysis, investigators characterized the heterogeneity of polymorphonuclear neutrophils in cancer. [Journal of Experimental Medicine] |
|
|
|
| Scientists observed that myeloma-associated macrophages derived from patients treated with the immunomodulatory drug lenalidomide skewed phenotypically and functionally toward an M1 phenotype. [Cancer Immunology Research] |
|
|
|
| The authors profiled genome-wide 5-methylcytosines in circulating cell-free DNA from 73 newly diagnosed patients with diffuse large B-cell lymphoma and follicular lymphoma. [npj Genomic Medicine] |
|
|
|
| Impact of adenosine on peripheral and cord blood mononuclear cells was analyzed by quantification of ectonucleotidases and adenosine receptor expression. [Pediatric Research] |
|
|
|
| Persons with HIV and diabetes have a high proportion of CX3CR1+ GPR56+ CD57+ CD4+ T cells in adipose tissue, a subset of which were cytomegalovirus specific, whereas individuals with diabetes but without HIV had predominantly CD69+ CD4+ T cells. [Cell Reports Medicine] |
|
|
|
|
| Scientists discuss the main sources of intratumoral heterogeneity and its impact on the natural history of the disease, including sensitivity to treatment, as they delineate potential strategies to target such a detrimental feature of aggressive malignancies. [Nature Medicine] |
|
|
|
| The authors review the current understanding of astrocyte interactions with microglia and the vasculature and protective barriers in the central nervous system as well as highlight recent insights into physiologic and reactive astrocyte sub-states identified by transcriptional profiling. [Immunity] |
|
|
|
|
| AIM ImmunoTech, Inc. announced that the Dutch Health and Youth Care Inspectorate has approved treatment for six pancreatic cancer patients as part of a new, follow-up Early Access Program at Erasmus Medical Center in the Netherlands. [AIM ImmunoTech, Inc.] |
|
|
|
|
| March 2 – 3, 2021 Virtual |
|
|
|
|
|
| The University of Texas Southwestern Medical Center – Dallas, Texas, United States |
|
|
|
| Duke University – Durham, North Carolina, United States |
|
|
|
| University of Washington – Seattle, Washington, United States |
|
|
|
| Oklahoma Medical Research Foundation – Oklahoma City, Oklahoma, United States |
|
|
|
| Memorial Sloan Kettering Cancer Center – New York, New York, United States |
|
|
|
|